Loading...
164: PARIS: a phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC).
Kordbacheh, Tiana Chan, Clara Bossons, Amy Franks, K McDonald, F Forster, M Mendes, R Quezada, S Dovedi, Simon J Ralph, C
Kordbacheh, Tiana
Chan, Clara
Bossons, Amy
Franks, K
McDonald, F
Forster, M
Mendes, R
Quezada, S
Dovedi, Simon J
Ralph, C
Citations
Altmetric:
Abstract
Description
Date
2017-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
164: PARIS: a phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). 2017, 103:S75 Lung Cancer